Should You Buy, Sell or Hold J&J Stock Ahead of Q4 Results?
JNJ heads into Q4 earnings with strong pharma and MedTech momentum, offset by Stelara biosimilar pressure and China-related headwinds.
JNJ - Johnson & Johnson
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$213.14
DETAILS
HIGH:
$240.00
LOW:
$190.00
MEDIAN:
$211.00
CONSENSUS:
$213.14
DOWNSIDE:
2.52%
Stock News
3 Dividend Stocks to Own No Matter Where the Market Moves in 2026
It is possible to build wealth through dividend investing. While it isn't guaranteed that your investment will grow, you'll continue to enjoy passive income as long as you hold the stock.
Winners & Losers: The ETF Playbook to Glide Trump's Great Healthcare Plan
Trump's Great Healthcare Plan redraws healthcare winners and losers - here's how ETFs like IHE could benefit as middlemen face pressure.
Hellman & Friedman Explores Potential Cordis Sale at Up to $10 Billion
People familiar with the matter said Hellman and Friedman is exploring a potential sale of Cordis, a cardiovascular medical device company focused on stents and r
Is Johnson & Johnson A Dividend Stock, Or Something Else?
Healthcare may be entering early mean reversion, but much of Johnson & Johnson's valuation recovery has already occurred. Post-Kenvue, JNJ is a higher-growth, less dividend-centric business,...
Johnson & Johnson: Tempering Expectations After A Massive 2025 (Downgrade)
Johnson & Johnson is downgraded to Hold, as valuation is now stretched after a 50% 12-month rally. JNJ trades above 21x forward EPS, exceeding its long-term average and offering a limited margin...
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
AbbVie has increased its dividend by 333% since 2013. Coca-Cola is a Dividend King that still has plenty of growth potential.
Rep. Julie Johnson Sells 3M Company (NYSE:MMM) Stock
Representative Julie Johnson (D-Texas) recently sold shares of 3M Company (NYSE: MMM). In a filing disclosed on January 15th, the Representative disclosed that they had sold between $1,001 and...
Rep. Julie Johnson Sells Verizon Communications Inc. (NYSE:VZ) Shares
Representative Julie Johnson (D-Texas) recently sold shares of Verizon Communications Inc. (NYSE: VZ). In a filing disclosed on January 15th, the Representative disclosed that they had sold...
Rep. Julie Johnson Sells Off Shares of Fidelity National Information Services, Inc. (NYSE:FIS)
Representative Julie Johnson (D-Texas) recently sold shares of Fidelity National Information Services, Inc. (NYSE: FIS). In a filing disclosed on January 15th, the Representative disclosed that...
Rep. Julie Johnson Sells Off Shares of Eaton Corporation, PLC (NYSE:ETN)
Representative Julie Johnson (D-Texas) recently sold shares of Eaton Corporation, PLC (NYSE: ETN). In a filing disclosed on January 15th, the Representative disclosed that they had sold between...
Rep. Julie Johnson Sells CMS Energy Corporation (NYSE:CMS) Stock
Representative Julie Johnson (D-Texas) recently sold shares of CMS Energy Corporation (NYSE: CMS). In a filing disclosed on January 15th, the Representative disclosed that they had sold between...
Rep. Julie Johnson Sells Deere & Company (NYSE:DE) Stock
Representative Julie Johnson (D-Texas) recently sold shares of Deere and Company (NYSE: DE). In a filing disclosed on January 15th, the Representative disclosed that they had sold between $1,001...
Home Depot (NYSE:HD) Shares Unloaded Rep. Julie Johnson
Representative Julie Johnson (D-Texas) recently sold shares of The Home Depot, Inc. (NYSE: HD). In a filing disclosed on January 15th, the Representative disclosed that they had sold between...
Rep. Julie Johnson Sells Off Shares of McDonald’s Corporation (NYSE:MCD)
Representative Julie Johnson (D-Texas) recently sold shares of McDonald's Corporation (NYSE: MCD). In a filing disclosed on January 15th, the Representative disclosed that they had sold between...
Rep. Julie Johnson Sells Merck & Co., Inc. (NYSE:MRK) Shares
Representative Julie Johnson (D-Texas) recently sold shares of Merck and Co., Inc. (NYSE: MRK). In a filing disclosed on January 15th, the Representative disclosed that they had sold between...
Rep. Julie Johnson Sells Off Shares of Wells Fargo & Company (NYSE:WFC)
Representative Julie Johnson (D-Texas) recently sold shares of Wells Fargo and Company (NYSE: WFC). In a filing disclosed on January 15th, the Representative disclosed that they had sold between...
Rep. Julie Johnson Sells Mondelez International, Inc. (NASDAQ:MDLZ) Shares
Representative Julie Johnson (D-Texas) recently sold shares of Mondelez International, Inc. (NASDAQ: MDLZ). In a filing disclosed on January 15th, the Representative disclosed that they had sold...
Rep. Julie Johnson Sells Walmart Inc. (NASDAQ:WMT) Shares
Representative Julie Johnson (D-Texas) recently sold shares of Walmart Inc. (NASDAQ: WMT). In a filing disclosed on January 15th, the Representative disclosed that they had sold between $1,001 and...
Bank of America (NYSE:BAC) Stock Unloaded Rep. Julie Johnson
Representative Julie Johnson (D-Texas) recently sold shares of Bank of America Corporation (NYSE: BAC). In a filing disclosed on January 15th, the Representative disclosed that they had sold...
Price Targets
Johnson & Johnson price target raised to $208 from $193 at Bernstein
$208.00
(was $205.75)
Lee Hambright
·
Bernstein
Johnson & Johnson (JNJ) PT Raised to $217 at Barclays
$217.00
(was $207.56)
Matt Miksic
·
Barclays
Johnson & Johnson price target raised to $240 from $213 at Goldman Sachs
$240.00
(was $210.33)
Asad Haider
·
Goldman Sachs
Johnson & Johnson price target raised to $240 from $230 at RBC Capital
$240.00
(was $209.07)
RBC Capital
Johnson & Johnson price target raised to $197 from $190 at Morgan Stanley
$197.00
(was $210.60)
Morgan Stanley
Johnson & Johnson price target raised to $230 from $209 at RBC Capital
$230.00
(was $206.54)
RBC Capital
Johnson & Johnson price target raised to $240 from $215 at HSBC
$240.00
(was $199.96)
HSBC
Johnson & Johnson price target raised to $227 from $206 at Guggenheim
$227.00
(was $202.48)
Guggenheim
Johnson & Johnson price target raised to $197 from $176 at Barclays
$197.00
(was $205.34)
Barclays
Johnson & Johnson downgraded to Hold from Buy at Freedom Capital
$190.00
(was $193.18)
Ilya Zubkov
·
Johnson Rice
Freedom Capital Markets Downgrades Johnson & Johnson (JNJ) to Hold
$190.00
(was $193.18)
Ilya Zubkov
·
Loop Capital Markets
Johnson & Johnson price target raised to $210 from $185 at Argus
$210.00
(was $191.19)
David Toung
·
Argus Research
Johnson & Johnson price target raised to $209 from $174 at Raymond James
$209.00
(was $190.85)
Raymond James
Johnson & Johnson price target raised to $190 from $178 at Morgan Stanley
$190.00
(was $190.85)
Terence Flynn
·
Morgan Stanley
Johnson & Johnson price target raised to $190 from $165 at Stifel
$190.00
(was $190.85)
Stifel Nicolaus
Johnson & Johnson price target raised to $214 from $190 at UBS
$214.00
(was $187.22)
UBS
Johnson & Johnson price target raised to $209 from $185 at RBC Capital
$209.00
(was $191.29)
Shagun Singh
·
RBC Capital
Johnson & Johnson price target raised to $193 from $172 at Bernstein
$193.00
(was $188.64)
Bernstein
Johnson & Johnson price target raised to $198 from $175 at BofA
$198.00
(was $185.98)
UBS
Wells upgrades Johnson & Johnson to Overweight on reduced concerns
$212.00
(was $185.98)
Larry Biegelsen
·
Wells Fargo